Loncar China BioPharma ETF (CHNA)
CHNA is a passive ETF by Exchange Traded Concepts tracking the investment results of the Loncar China BioPharma Index. CHNA launched on Aug 14, 2018 and has a 0.79% expense ratio.
ETF Info
US26922A3703
26922A370
Aug 14, 2018
Emerging Asia Pacific (China)
1x
Loncar China BioPharma Index
Multi-Cap
Blend
Expense Ratio
CHNA features an expense ratio of 0.79%, falling within the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Loncar China BioPharma ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
CHNA
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
4.22%
2.22%
9.51%
22.46%
12.74%
11.29%
Monthly Returns
The table below presents the monthly returns of CHNA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 12.67% | -9.21% | -7.24% | 2.80% | -11.29% | -0.38% | 4.45% | -11.34% | -4.83% | -99.46% | -3.95% | -13.70% | -99.66% |
| 2022 | -16.26% | -0.48% | -8.21% | -11.01% | -1.40% | 11.30% | -6.40% | -5.02% | -19.19% | 0.94% | 24.87% | 3.70% | -29.85% |
| 2021 | 12.26% | 3.62% | -2.63% | 11.84% | 9.27% | 5.48% | -12.51% | -8.95% | -1.53% | -10.45% | -0.18% | -10.37% | -8.23% |
| 2020 | -2.81% | 4.61% | -9.90% | 10.25% | 7.17% | 14.52% | 2.58% | 0.48% | -3.02% | -3.47% | 3.36% | 6.74% | 31.94% |
| 2019 | 9.71% | 6.54% | 5.93% | -0.17% | -8.59% | 2.44% | 1.49% | 1.44% | -4.61% | 9.39% | 0.84% | 3.27% | 29.48% |
| 2018 | 5.51% | -8.02% | -15.53% | 14.30% | -13.99% | -19.40% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Loncar China BioPharma ETF (CHNA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
| Period | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Dividend | $0.05 | $0.00 | $3.03 | $0.15 | $0.04 |
Dividend yield | 77.30% | 0.00% | 11.33% | 0.47% | 0.16% |
Monthly Dividends
The table displays the monthly dividend distributions for Loncar China BioPharma ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | |||||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.05 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.03 | $3.03 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.15 |
| 2019 | $0.04 | $0.04 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Loncar China BioPharma ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Loncar China BioPharma ETF was 99.88%, occurring on Dec 8, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.88% | Jun 29, 2021 | 580 | Dec 8, 2023 | — | — | — |
| -30.37% | Aug 28, 2018 | 79 | Jan 3, 2019 | 255 | Jan 16, 2020 | 334 |
| -22.92% | Feb 19, 2020 | 19 | Mar 16, 2020 | 43 | May 15, 2020 | 62 |
| -16.62% | Feb 18, 2021 | 13 | Mar 8, 2021 | 35 | Apr 27, 2021 | 48 |
| -13.47% | Aug 6, 2020 | 62 | Nov 2, 2020 | 46 | Jan 8, 2021 | 108 |
Volatility
Volatility Chart
The current Loncar China BioPharma ETF volatility is 492.38%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.